HPR50 Exploring the Contribution of Health Gains and Cost-Offsets to Value-Based Drug Prices in Prior ICER Reviews

Abstract

Authors

M. Richardson M. Whittington A. Moradi J. Campbell

Full Text Cite This Article
Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×